{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "9788894", "DateCompleted": {"Year": "2000", "Month": "07", "Day": "25"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0091-6765", "JournalIssue": {"Volume": "106 Suppl 5", "Issue": "Suppl 5", "PubDate": {"Year": "1998", "Month": "Oct"}}, "Title": "Environmental health perspectives", "ISOAbbreviation": "Environ Health Perspect"}, "ArticleTitle": "Increased nitric oxide synthase in the lung after ozone inhalation is associated with activation of NF-kappa B.", "Pagination": {"StartPage": "1175", "EndPage": "1178", "MedlinePgn": "1175-8"}, "Abstract": {"AbstractText": ["Acute inhalation of ozone is associated with a inflammatory response characterized by the accumulation of macrophages at sites of tissue injury. These cells, along with resident alveolar epithelial cells, become activated and release cytotoxic and proinflammatory mediators, such as nitric oxide (.NO), that we speculate contribute to toxicity. In these studies we analyzed mechanisms regulating increased .NO synthase activity in lung macrophages and type II cells after ozone inhalation. Brief exposure of rats to ozone (2 ppm for 3 hr) resulted in an increase in .NO production by alveolar macrophages as well as type II cells in response to the inflammatory mediators lipopolysaccharide and interferon gamma. These effects were apparently due to increased expression of inducible .NO synthase (iNOS) protein and mRNA, which were evident in vitro and in situ in histologic sections. .NO production and iNOS protein expression by both macrophages and epithelial cells were blocked by pyrrolidine dithiocarbamate (PDTC), an agent that inhibits activity of nuclear transcription factor kappa B (NF-kappa B). Cells from ozone-treated animals were less sensitive to the effects of PDTC than cells from control animals. Using electrophoretic mobility shift assays, we measured NF-kappa B binding activity in nuclear extracts of cells from control and ozone-exposed animals. Treatment of rats with ozone resulted in a time-dependent increase in NF-kappa B binding activity in both cell types, reaching a maximum in cells isolated 12 to 24 hr after ozone inhalation. Taken together, these data suggest that changes in the activity of NF-kappa B signaling are important in the response of lung macrophages and type II epithelial cells to cytokines after ozone inhalation."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Environmental and Occupational Health Sciences Institute, Rutgers University, Piscataway, New Jersey 08854-8020, USA. laskin@eohsi.rutgers.edu"}], "Identifier": [], "LastName": "Laskin", "ForeName": "D L", "Initials": "DL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Sunil", "ForeName": "V", "Initials": "V"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Guo", "ForeName": "Y", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Heck", "ForeName": "D E", "Initials": "DE"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Laskin", "ForeName": "J D", "Initials": "JD"}], "GrantList": [{"GrantID": "ES04738", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "ES05022", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "ES06897", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Environ Health Perspect", "NlmUniqueID": "0330411", "ISSNLinking": "0091-6765"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "DNA Probes"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Messenger"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase Type II"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nos2 protein, rat"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Base Sequence"}, {"QualifierName": ["genetics"], "DescriptorName": "DNA Probes"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Epithelial Cells"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression"}, {"QualifierName": ["cytology", "drug effects", "metabolism"], "DescriptorName": "Lung"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Macrophages, Alveolar"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Nitric Oxide Synthase"}, {"QualifierName": [], "DescriptorName": "Nitric Oxide Synthase Type II"}, {"QualifierName": ["toxicity"], "DescriptorName": "Ozone"}, {"QualifierName": ["cytology", "drug effects", "metabolism"], "DescriptorName": "Pulmonary Alveoli"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "RNA, Messenger"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "J Inflamm. 1998;48(2):56-66", "ArticleIdList": ["9656142"]}, {"Citation": "J Mol Med (Berl). 1996 Dec;74(12):749-69", "ArticleIdList": ["8974017"]}, {"Citation": "Methods. 1996 Aug;10(1):61-70", "ArticleIdList": ["8812646"]}, {"Citation": "Annu Rev Pharmacol Toxicol. 1995;35:655-77", "ArticleIdList": ["7598511"]}, {"Citation": "J Immunol. 1993 May 15;150(10):4561-70", "ArticleIdList": ["8482848"]}, {"Citation": "J Exp Med. 1992 May 1;175(5):1181-94", "ArticleIdList": ["1314883"]}, {"Citation": "J Clin Invest. 1990 Dec;86(6):1945-53", "ArticleIdList": ["2254454"]}, {"Citation": "Am J Respir Cell Mol Biol. 1995 Aug;13(2):125-32", "ArticleIdList": ["7542894"]}, {"Citation": "J Biol Chem. 1991 Mar 5;266(7):4244-50", "ArticleIdList": ["1847917"]}, {"Citation": "Am J Respir Cell Mol Biol. 1992 Jan;6(1):9-16", "ArticleIdList": ["1728301"]}, {"Citation": "Biochem Soc Trans. 1993 May;21(2):330-4", "ArticleIdList": ["8395426"]}, {"Citation": "Am J Respir Cell Mol Biol. 1994 Aug;11(2):165-72", "ArticleIdList": ["7519435"]}, {"Citation": "Anal Biochem. 1982 Oct;126(1):131-8", "ArticleIdList": ["7181105"]}, {"Citation": "Am J Respir Cell Mol Biol. 1993 Apr;8(4):384-92", "ArticleIdList": ["8476632"]}, {"Citation": "FASEB J. 1992 Sep;6(12):3051-64", "ArticleIdList": ["1381691"]}, {"Citation": "Am J Respir Cell Mol Biol. 1994 Sep;11(3):279-86", "ArticleIdList": ["8086166"]}, {"Citation": "J Immunol. 1993 Dec 15;151(12):7196-205", "ArticleIdList": ["7505023"]}, {"Citation": "Am Rev Respir Dis. 1986 Jul;134(1):141-5", "ArticleIdList": ["3637065"]}, {"Citation": "Am J Respir Cell Mol Biol. 1996 Jun;14(6):516-25", "ArticleIdList": ["8652180"]}, {"Citation": "J Biol Chem. 1994 Feb 18;269(7):4705-8", "ArticleIdList": ["7508926"]}, {"Citation": "Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8458-62", "ArticleIdList": ["7667311"]}]}], "History": [{"Year": "1998", "Month": "10", "Day": "28", "Hour": "3", "Minute": "1"}, {"Year": "2000", "Month": "8", "Day": "1", "Hour": "11", "Minute": "0"}, {"Year": "1998", "Month": "10", "Day": "28", "Hour": "3", "Minute": "1"}, {"Year": "1998", "Month": "10", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9788894", "PMC1533360", "10.1289/ehp.98106s51175", "sc271_5_1835"]}}], "PubmedBookArticle": []}